Something new
is taking shape.
We’re building something exciting and are looking forward to sharing more with you soon.
Navigo Proteins’ Precision Targeting will soon take on a new form. The first glimpse of this transformation: a fresh name for the future of precision medicine – Navigo Precision.
While our new website is under construction, this page offers a first peak at who we are and what we stand for.
Discover more about us
Navigo Precision focuses on AI-driven next-generation targeted therapies and diagnostics, leveraging a modular protein engineering platform and collaborating with partners from early discovery through translation into the clinic. Our platform is based on a novel targeting modality, Affilins®, whose modular architecture enables the design of mono-, bi-, or multispecific Affilin®-based drug candidates through coupling to different effectors.
Download our company flyer to learn more about our approach, capabilities, and application areas.
Let’s connect
Have questions, want to explore a collaboration, or discuss a specific application?
Simply leave us a message and we’ll get back to you as soon as possible.
"*" indicates required fields